Clinical Trial Update: Empagliflozin in Patients With Cirrhosis and Ascites [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating empagliflozin in patients with cirrhosis and ascites is currently recruiting at Yale University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Liver Failure

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Yale University | Conditions: Cirrhosis, Liver Failure | Phase 2 | Status: RECRUITING